- http://www.marketwatch.com/story...220?mod=mw_rss_topstoriesAdani Group companies lost $26 billion in market cap on Thursday, after the U.S. alleged that founder and chairman Gautam Adani was involved in a $250 million bribery scheme.Posted 18 minutes 57 seconds ago - 11/21/24
- http://www.marketwatch.com/story...b56?mod=mw_rss_topstoriesNvidia’s GAAP gross margins — forecast at 73% for the company’s fiscal fourth quarter — are still enviable across the semiconductor industry.Posted 6 hours 9 minutes ago - 11/20/24
- http://www.marketwatch.com/story...553?mod=mw_rss_topstoriesKelly Ortberg had a tough message for Boeing employees, including that the company is at a ‘low’ as employees spend more time arguing among themselves than figuring out how to beat Airbus.Posted 8 hours 35 minutes ago - 11/20/24
- http://www.marketwatch.com/story...fb9?mod=mw_rss_topstoriesA weekly look at the most important news and moves in crypto, and what’s on the horizon in digital assets.Posted 9 hours 2 minutes ago - 11/20/24
- http://www.marketwatch.com/story...d8a?mod=mw_rss_topstoriesMerely in-line expectations for cybersecurity company’s fiscal year drags on the stock.Posted 9 hours 41 minutes ago - 11/20/24
- http://www.marketwatch.com/story...146?mod=mw_rss_topstoriesSnowflake’s last three earnings reports spurred negative stock reactions, but investors seem to like the company’s upbeat guidance this time aroundPosted 10 hours 13 minutes ago - 11/20/24
- http://www.marketwatch.com/story...ff0?mod=mw_rss_topstoriesGameStop co-founder Gary Kusin sees parallels between Swifties and the videogame retailer’s intensely loyal fans.Posted 10 hours 43 minutes ago - 11/20/24
- http://www.marketwatch.com/story...19d?mod=mw_rss_topstoriesChewy shares charged up to fresh highs for the year on Wednesday, as BofA Securities reversed course to be the most bullish on Wall Street toward the online pet-products retailer, after being the lone bear.Posted 11 hours 21 minutes ago - 11/20/24
- http://www.marketwatch.com/story...ca6?mod=mw_rss_topstoriesGold prices have been showing signs of life against a backdrop of worrisome headlines tied to the Russia-Ukraine war — but one analyst said investors should take advantage of pullbacks to buy the metal ahead of a potential climb toward $3,000 an ounce next year.Posted 12 hours 56 seconds ago - 11/20/24
- http://www.marketwatch.com/story...ff7?mod=mw_rss_topstoriesQualcomm seems to be preparing for a world without Apple business, but one analyst thinks the company’s PC targets look aggressive.Posted 13 hours 15 minutes ago - 11/20/24
- http://www.marketwatch.com/story...6af?mod=mw_rss_topstoriesTwo of the U.S. government’s most powerful banking regulators said, in response to pointed questions about their futures from Republicans on the House Financial Services Committee, that they have no plans to step down.Posted 14 hours 19 minutes ago - 11/20/24
- http://www.marketwatch.com/story...69b?mod=mw_rss_topstoriesThe biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.Posted 14 hours 30 minutes ago - 11/20/24
- http://www.marketwatch.com/story...f05?mod=mw_rss_topstoriesAn analyst cheers the potential for more live programming — and perhaps a stock split next year.Posted 14 hours 42 minutes ago - 11/20/24
- http://www.marketwatch.com/story...4a1?mod=mw_rss_topstoriesFord outlined plans to lay off 4,000 employees in the U.K. and Germany in response to a series of losses it blamed on unprecedented competitive, regulatory and economic headwinds in Europe’s car market.Posted 15 hours 47 minutes ago - 11/20/24
- http://www.marketwatch.com/story...c8f?mod=mw_rss_topstories“I had no job and no unemployment benefits.”Posted 15 hours 53 minutes ago - 11/20/24
- http://www.marketwatch.com/story...678?mod=mw_rss_topstoriesHigh equity valuations and investors’ concentration in big U.S. tech stocks are among the main risks to financial stability, says the ECBPosted 15 hours 58 minutes ago - 11/20/24
- http://www.marketwatch.com/story...7fa?mod=mw_rss_topstories“I will receive $105,000 per year in retirement. I earn $135,000 a year now.”Posted 16 hours 3 minutes ago - 11/20/24
- http://www.marketwatch.com/story...8ed?mod=mw_rss_topstoriesAs people plan out their budgets for 2025, there’s a chance for high earners to supercharge their retirement savings using the “mega-backdoor Roth” strategy — a rare but increasingly popular option for employer-sponsored 401(k)s.Posted 16 hours 48 minutes ago - 11/20/24
- http://www.marketwatch.com/story...462?mod=mw_rss_topstoriesInvestors are often hopeful spinoffs will lead to improved valuations. But one analyst questioned whether that will play out for Comcast given the decay of legacy media.Posted 17 hours 11 minutes ago - 11/20/24
- http://www.marketwatch.com/story...f4e?mod=mw_rss_topstoriesRetailer lifts its outlook for operating profit margin despite challenging market conditions.Posted 17 hours 33 minutes ago - 11/20/24
- http://www.marketwatch.com/story...9be?mod=mw_rss_topstoriesCrude-oil prices climbed on Wednesday, building on gains from earlier in the week as traders assessed fresh supply data while monitoring geopolitical developments on several fronts.Posted 18 hours 11 minutes ago - 11/20/24
- http://www.marketwatch.com/story...144?mod=mw_rss_topstoriesDelta Air Lines Inc. on Wednesday said it sees an opportunity to tap into affluent travelers as it laid out its long-term goals the next three-to-five years.Posted 18 hours 27 minutes ago - 11/20/24
- http://www.marketwatch.com/story...89b?mod=mw_rss_topstoriesSame-stores sales rose 7% at discounter’s international segmentPosted 18 hours 37 minutes ago - 11/20/24
- http://www.marketwatch.com/story...d85?mod=mw_rss_topstoriesThe drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.Posted 19 hours 56 seconds ago - 11/20/24
- http://www.marketwatch.com/story...9f1?mod=mw_rss_topstoriesIt was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease.Posted 19 hours 56 seconds ago - 11/20/24
As of Thu, Nov 21, 01:20 AM CST